US Stock MarketDetailed Quotes

ARTV Artiva Biotherapeutics

Watchlist
  • 11.300
  • +0.300+2.73%
Close Aug 9 16:00 ET
  • 11.300
  • 0.0000.00%
Post 20:02 ET
263.08MMarket Cap-10134P/E (TTM)

Artiva Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
Total revenue
-74.62%251K
579.21%33.49M
-26.63%989K
146.30%4.93M
1,114.41%1.35M
2M
1.42M
111K
0
0
Operating revenue
--0
567.67%32.92M
-26.63%989K
146.30%4.93M
1,114.41%1.35M
--2M
--1.42M
--111K
--0
--0
Cost of revenue
Gross profit
Operating expense
-21.06%14.74M
-0.92%64.16M
38.64%18.68M
17.16%64.76M
-44.51%13.47M
202.52%55.27M
111.21%12.81M
24.28M
18.27M
6.07M
Selling and administrative expenses
-8.17%3.59M
-33.04%13.91M
3.69%3.91M
61.50%20.78M
41.78%3.77M
190.65%12.86M
154.72%4.32M
--2.66M
--4.43M
--1.7M
-General and administrative expense
-8.17%3.59M
-33.04%13.91M
3.69%3.91M
61.50%20.78M
41.78%3.77M
190.65%12.86M
154.72%4.32M
--2.66M
--4.43M
--1.7M
Research and development costs
-24.47%11.16M
14.25%50.25M
52.20%14.77M
3.71%43.98M
-55.12%9.71M
206.32%42.41M
94.33%8.49M
--21.62M
--13.85M
--4.37M
Operating profit
18.07%-14.49M
48.74%-30.67M
-45.89%-17.69M
-12.31%-59.83M
49.84%-12.12M
-191.57%-53.27M
-87.77%-11.39M
-24.17M
-18.27M
-6.07M
Net non-operating interest income expense
-36.52%650K
95.90%2.54M
1.02M
1.29M
0
0
-197K
0
Non-operating interest income
-36.52%650K
95.90%2.54M
--1.02M
--1.29M
----
--0
--0
----
--2K
--0
Non-operating interest expense
----
----
----
----
----
--0
--0
----
--199K
--0
Other net income (expense)
-128.30%-121K
156.00%512K
-53K
101.08%200K
-3,989.52%-18.55M
0
-18.55M
477K
136K
Gain on sale of security
---268K
--707K
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
377.36%147K
-197.50%-195K
---53K
101.08%200K
----
-3,989.52%-18.55M
--0
---18.55M
--477K
--136K
Income before tax
16.47%-13.96M
52.65%-27.62M
-37.88%-16.72M
18.78%-58.34M
71.62%-12.12M
-299.23%-71.83M
-92.08%-11.39M
-42.72M
-17.99M
-5.93M
Income tax
35.85%72K
53K
Net income
16.47%-13.96M
52.57%-27.7M
-37.88%-16.72M
18.71%-58.39M
71.62%-12.12M
-299.23%-71.83M
-92.08%-11.39M
-42.72M
-17.99M
-5.93M
Net income continuous Operations
16.47%-13.96M
52.57%-27.7M
-37.88%-16.72M
18.71%-58.39M
71.62%-12.12M
-299.23%-71.83M
-92.08%-11.39M
---42.72M
---17.99M
---5.93M
Minority interest income
Net income attributable to the parent company
16.47%-13.96M
52.57%-27.7M
-37.88%-16.72M
18.71%-58.39M
71.62%-12.12M
-299.23%-71.83M
-92.08%-11.39M
-42.72M
-17.99M
-5.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
16.47%-13.96M
52.57%-27.7M
-37.88%-16.72M
18.71%-58.39M
71.62%-12.12M
-299.23%-71.83M
-92.08%-11.39M
-42.72M
-17.99M
-5.93M
Basic earnings per share
16.56%-1.49
50.78%-3.07
-37.88%-1.7857
18.71%-6.237
71.62%-1.2951
-299.23%-7.6723
-92.08%-1.2169
-4.5636
-1.9218
-0.6335
Diluted earnings per share
16.56%-1.49
50.78%-3.07
-37.88%-1.7857
18.71%-6.237
71.62%-1.2951
-299.23%-7.6723
-92.08%-1.2169
-4.5636
-1.9218
-0.6335
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020
Total revenue -74.62%251K579.21%33.49M-26.63%989K146.30%4.93M1,114.41%1.35M2M1.42M111K00
Operating revenue --0567.67%32.92M-26.63%989K146.30%4.93M1,114.41%1.35M--2M--1.42M--111K--0--0
Cost of revenue
Gross profit
Operating expense -21.06%14.74M-0.92%64.16M38.64%18.68M17.16%64.76M-44.51%13.47M202.52%55.27M111.21%12.81M24.28M18.27M6.07M
Selling and administrative expenses -8.17%3.59M-33.04%13.91M3.69%3.91M61.50%20.78M41.78%3.77M190.65%12.86M154.72%4.32M--2.66M--4.43M--1.7M
-General and administrative expense -8.17%3.59M-33.04%13.91M3.69%3.91M61.50%20.78M41.78%3.77M190.65%12.86M154.72%4.32M--2.66M--4.43M--1.7M
Research and development costs -24.47%11.16M14.25%50.25M52.20%14.77M3.71%43.98M-55.12%9.71M206.32%42.41M94.33%8.49M--21.62M--13.85M--4.37M
Operating profit 18.07%-14.49M48.74%-30.67M-45.89%-17.69M-12.31%-59.83M49.84%-12.12M-191.57%-53.27M-87.77%-11.39M-24.17M-18.27M-6.07M
Net non-operating interest income expense -36.52%650K95.90%2.54M1.02M1.29M00-197K0
Non-operating interest income -36.52%650K95.90%2.54M--1.02M--1.29M------0--0------2K--0
Non-operating interest expense ----------------------0--0------199K--0
Other net income (expense) -128.30%-121K156.00%512K-53K101.08%200K-3,989.52%-18.55M0-18.55M477K136K
Gain on sale of security ---268K--707K--------------------------------
Other non- operating income (expenses) 377.36%147K-197.50%-195K---53K101.08%200K-----3,989.52%-18.55M--0---18.55M--477K--136K
Income before tax 16.47%-13.96M52.65%-27.62M-37.88%-16.72M18.78%-58.34M71.62%-12.12M-299.23%-71.83M-92.08%-11.39M-42.72M-17.99M-5.93M
Income tax 35.85%72K53K
Net income 16.47%-13.96M52.57%-27.7M-37.88%-16.72M18.71%-58.39M71.62%-12.12M-299.23%-71.83M-92.08%-11.39M-42.72M-17.99M-5.93M
Net income continuous Operations 16.47%-13.96M52.57%-27.7M-37.88%-16.72M18.71%-58.39M71.62%-12.12M-299.23%-71.83M-92.08%-11.39M---42.72M---17.99M---5.93M
Minority interest income
Net income attributable to the parent company 16.47%-13.96M52.57%-27.7M-37.88%-16.72M18.71%-58.39M71.62%-12.12M-299.23%-71.83M-92.08%-11.39M-42.72M-17.99M-5.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 16.47%-13.96M52.57%-27.7M-37.88%-16.72M18.71%-58.39M71.62%-12.12M-299.23%-71.83M-92.08%-11.39M-42.72M-17.99M-5.93M
Basic earnings per share 16.56%-1.4950.78%-3.07-37.88%-1.785718.71%-6.23771.62%-1.2951-299.23%-7.6723-92.08%-1.2169-4.5636-1.9218-0.6335
Diluted earnings per share 16.56%-1.4950.78%-3.07-37.88%-1.785718.71%-6.23771.62%-1.2951-299.23%-7.6723-92.08%-1.2169-4.5636-1.9218-0.6335
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Recent IPOs
Recent IPOs
Intraday-0.62%